Drug Ploy Stopping Executions, But There's a Remedy

eTradeWire News/10488901
"Showdown" in a "Guerrilla War Against Death Penalty" Friday

WASHINGTON - Aug. 9, 2018 - eTradeWire -- Having already stopped one execution in Nevada with a novel legal argument by a drug company, opponents of the death penalty will try to use it again in what they label a "showdown" in a "guerrilla war against the death penalty" at a hearing scheduled for 3:00 PM Friday before Senior U.S. District Judge Richard Kopf in Nebraska.

If they are again successful in stopping Carey Dean Moore's Nebraska execution, as they were in using the argument to stop the scheduled execution of murderer Scott Raymond Dozier in Nevada, many claim that this new ploy will halt any execution in the overwhelming majority of states - 31- in which it is legal and authorized.

Opponent have pressured several drug companies to object to the use of their drugs in executions, and to argue that - even if the source of the drugs cannot be established by the plaintiffs - the state may have obtained the injectable drugs by "fraud, deceit or misrepresentation."  This argument has caused several judges to stop scheduled executions, most recently in Nevada.

But, notes public interest law professor John Banzhaf, this is contrary to the general rule of law that a manufacturer has no right to dictate how its product is used once it has been sold.

A paint manufacturer cannot stop the use of its paint to produce a sign or billboard with a horribly offensive message to which the company strongly objects, any more than the maker of a video camera can object if it is used to create movies which are obscene or contain highly offensive content to which the company opposes, notes Banzhaf, and this is true even if the products were obtained from a third party by "fraud, deceit or misrepresentation."

More on eTradeWire News
Here, Nebraska state Senator Ernie Chambers, in a letter to Pfizer asking it to bring the same kind of legal action to prevent the scheduled execution of Carey Dean Moore, cited the Dozier success; a tactic which Banzhaf predicted would be used more and more by those who oppose the death penalty.

It may well take a law suit, notes Banzhaf, since Pfizer said in a statement that it strongly objected to the use of its drugs for executions, and demanded the return of any of its drugs Nebraska intends "to misuse in a lethal injection procedure."  However, Nebraska refused the request.  This new case arises out of an objection from drug maker Fresenius Kabi.

In the case of Scott Raymond Dozier, it was claimed that one of the three drugs to be used in a three-drug "execution cocktail" had been obtained by the state through "subterfuge" because it had been shipped to a third party before being turned over to Nevada.  For this reason, Clark County District Court Judge Elizabeth Gonzalez stopped the planned execution.

Many drug makers have stated publicly that they do not want their products used in executions, but it is not at all clear that simply stating such opposition is enough to shut down a scheduled execution.  However, under this new tactic, anything other than complete transparency in obtaining an injectable drug could bring death penalty opponents the victory they desire, especially if that argument is made by the drug maker.

The problem with using injectable drugs for executions is further complicated by the fact that federal judge Richard Leon has enjoined the importation of most of these drugs, and even ordered any correctional departments in possession of the drugs to return them to the FDA, because these execution drugs cannot meet the test of being both safe and effective for their intended use.

More on eTradeWire News
The simple answer, and alternative to using injectable drugs for executions with the many challenges this method faces, is putting the condemned on the pill, says Banzhaf.

Since most of the concerns of using drugs for capital punishment involve problems - including  artificial scarcity and expiration dates - with drugs which are injected, an obvious alternative for meeting any constitutional problems, as well as arguments by drug companies objecting to the use of their product for capital punishment, would be for states to simply use readily available pills rather than injections to administer drugs such as barbiturates whose lethal properties are well controlled, well known, and very clearly established.

"Providing a condemned man with barbiturate pills to cause a quick and painless death - as in 'death with dignity' jurisdictions - is well tested, established, and accepted, does not require any trained personnel, and could avoid the many medical and other problems with injections, as well as restrictions on injectable drugs imposed by many manufacturers because of ethical and moral concerns," suggests Banzhaf.

Barbiturate pills are approved for certain medical uses, and are even covered by Medicare Part D.   So the common and generally accepted practice of prescribing drugs for "off-label use" - using a drug approved for one purpose to do something else - would seemingly permit states to use barbiturate pills in executions, and perhaps even allow them to be imported from abroad or through third parties if necessary, says Banzhaf.

Interestingly, Arizona just approved the use of barbiturates for executions, but only if injected.

However, in six states - California, Colorado, Montana, Oregon, Vermont, and Washington - physicians are permitted to prescribe barbiturate pills so that terminally ill patients can achieve death with dignity, and the pills for this purpose are readily available, and do not expire quickly, or require refrigeration, as injectable drugs often do.

"If this method is appropriate for totally innocent and often frail elderly people seeking a quick and painless death with dignity, it should be more than good enough for murderers," Banzhaf argues.

http://banzhaf.net/ jbanzhaf3ATgmail.com  @profbanzhaf

Contact
GW LAW
***@gwu.edu


Source: Public Interest Law Professor John Banzhaf
Filed Under: Government

Show All News | Report Violation

0 Comments

Latest on eTradeWire News